5.16
-0.16 (-3.01%)
| Penutupan Terdahulu | 5.32 |
| Buka | 5.22 |
| Jumlah Dagangan | 213,424 |
| Purata Dagangan (3B) | 264,325 |
| Modal Pasaran | 272,818,144 |
| Harga / Jualan (P/S) | 3.66 |
| Harga / Buku (P/B) | 4.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Mar 2026 |
| Margin Keuntungan | -63.24% |
| Margin Operasi (TTM) | -79.16% |
| EPS Cair (TTM) | -0.980 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.12% |
| Nisbah Semasa (MRQ) | 10.47 |
| Aliran Tunai Operasi (OCF TTM) | -24.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.84 M |
| Pulangan Atas Aset (ROA TTM) | -21.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Sight Sciences, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.38 |
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.87% |
| % Dimiliki oleh Institusi | 50.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Kck Ltd. | 30 Sep 2025 | 4,374,975 |
| Americana Partners, Llc | 31 Dec 2025 | 1,378,980 |
| B Group, Inc. | 31 Dec 2025 | 920,000 |
| Integral Health Asset Management, Llc | 31 Dec 2025 | 425,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 12.00 (Lake Street, 132.56%) | Beli |
| Median | 9.00 (74.42%) | |
| Rendah | 6.50 (Citigroup, 25.97%) | Pegang |
| Purata | 9.30 (80.23%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 5.82 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 06 Mar 2026 | 6.50 (25.97%) | Pegang | 3.66 |
| 11 Dec 2025 | 9.10 (76.36%) | Pegang | 8.28 | |
| UBS | 06 Mar 2026 | 11.00 (113.18%) | Beli | 3.66 |
| 23 Dec 2025 | 12.00 (132.56%) | Beli | 8.44 | |
| Stifel | 02 Mar 2026 | 8.00 (55.04%) | Beli | 5.62 |
| Piper Sandler | 05 Jan 2026 | 9.00 (74.42%) | Beli | 7.71 |
| Lake Street | 10 Dec 2025 | 12.00 (132.56%) | Beli | 8.46 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2026 | Pengumuman | Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |